not tagged
not tagged
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'immunic']
results from our advance ii trial in #amlmaintenance were presented at #eha2022 by our collaborator 's prof arjan van de loosdrecht. the data underpins the strong predictive value of #mrdresponse for #rfs. to refresh your memory on advance ii: 
Immunicum (Nasdaq Stockholm: https://t.co/qpPeKLArK7) is establishing a leader in cell-based immunotherapies built on decades of expertise in #allogeneic dendritic cell biology